JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sciacca, R. R.
Right arrow Articles by Bergmann, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sciacca, R. R.
Right arrow Articles by Bergmann, S. R.
Journal of Nuclear Medicine Vol. 42 No. 1 63-70
© 2001 by Society of Nuclear Medicine


CLINICAL INVESTIGATIONS

Measurement of Myocardial Blood Flow with PET Using 1-11C-Acetate

Robert R. Sciacca, Olakunle Akinboboye, Ru Ling Chou, Shilpi Epstein and Steven R. Bergmann

Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York

11C-acetate has been used extensively for the noninvasive assessment of myocardial oxygen consumption and viability with PET. The use of early uptake of acetate by the heart to measure myocardial perfusion has been proposed. This study evaluated the application of 11C-acetate for absolute measurement of myocardial blood flow using a simple compartmental model that does not require blood sampling. Methods: Eight healthy volunteers and 13 subjects with concentric left ventricular hypertrophy were studied under resting conditions with both 11C-acetate and 15O-water. Myocardial blood flow with 11C-acetate was obtained by fitting the first 3 min of the blood and tissue tracer activity curves to a two-compartment model. Flows obtained were compared with a validated approach using 15O-water. Results: In healthy volunteers, regional myocardial perfusion at rest estimated with 11C-acetate was comparable with values obtained with 15O-water (1.06 ± 0.25 and 0.96 ± 0.12 mL/g/min, respectively). Perfusion in subjects with left ventricular hypertrophy was also comparable if the recovery coefficient (FMM) used was corrected for ventricular mass. If a fixed FMM was used, flow was greatly overestimated. FMM could be estimated from left ventricular mass (FMM = 0.46 + 0.002 x mass, r = 0.86, P < 0.0001). Conclusion: The results of this study suggest that 11C-acetate can be applied to quantitatively estimate myocardial perfusion under resting conditions using a two-compartment model without the need for blood sampling, provided that an appropriate FMM is chosen. This approach should increase the usefulness of this tracer and obviate administration of a separate tracer to independently measure perfusion.

Key Words: PET • myocardial blood flow • 1-11C-acetate




This article has been cited by other articles:


Home page
JNMHome page
C. Schiepers, C. K. Hoh, J. Nuyts, M. Seltzer, C. Wu, S.-C. Huang, and M. Dahlbom
1-11C-Acetate Kinetics of Prostate Cancer
J. Nucl. Med., February 1, 2008; 49(2): 206 - 215.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Golman, J. H. Ardenkjaer-Larsen, J. S. Petersson, S. Mansson, and I. Leunbach
Molecular imaging with endogenous substances
PNAS, September 2, 2003; 100(18): 10435 - 10439.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. van den Hoff, R. R. Sciacca, and S. R. Bergmann
Methodologic Aspects of Myocardial Blood Flow Quantification with 1-11C-Acetate Pet
J. Nucl. Med., September 1, 2001; 42(9): 1438 - 1438.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.